Basic Information
Basic information for MIR9-3HG-219-15aa
Peptide Name MIR9-3HG-219-15aa
Genome Position chr15:89398078-89398122[+]
Species Human
Peptide Sequence MPSPGFCPNLNWAVG
Peptide Length 15
Unique No (MIR9-3HG-201-15aa,MIR9-3HG-212-15aa,MIR9-3HG-213-15aa,MIR9-3HG-214-15aa,MIR9-3HG-218-15aa,MIR9-3HG-220-15aa,MIR9-3HG-221-15aa,MIR9-3HG-222-15aa,MIR9-3HG-226-15aa,MIR9-3HG-227-15aa,MIR9-3HG-233-15aa,MIR9-3HG-241-15aa,MIR9-3HG-246-15aa,MIR9-3HG-247-15aa,MIR9-3HG-251-15aa,MIR9-3HG-252-15aa,MIR9-3HG-253-15aa)
Grand Average of Hydropathicity 0.18
Relative Molecular Mass 1842.05
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000255571;MIR9-3HG
Transcript ID/Name ENST00000658194;MIR9-3HG-219
Transcript Length 4266
Coding Ability 0.4834
DNA Sequence Corresponding to Peptide ATGCCATCCCCTGGGTTTTGCCCAAACCTGAACTGGGCAGTGGGG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :